A study from Maastricht in the Netherlands found that using 150mg of resveratrol supplements daily for six months can reduce the level of glycosylated hemoglobin (HbA1). DSM's resveratrol was used in the study.
This double-blind controlled study recruited 41 participants and randomly divided them into two groups. The resveratrol group received 150ng of resveratrol supplements per day (once at noon and at night, 75mg each time). The researchers tested the participants' weight, blood pressure and related parameters, including liver fat content, body index, resting energy metabolism, blood pressure, plasma indicators, physical performance, quality of life, and sleep quality.
The study concluded that the insulin sensitivity of the two groups of people was not affected, and there were no significant changes in liver fat consumption, body index, energy metabolism, sports insurance, and quality of life and sleep. But the level of glycosylated hemoglobin decreased from 37.6mmol/mol to 35.8mmol/mol. The glycosylated hemoglobin level is a long-term blood glucose control marker, which reflects the average blood glucose value for three consecutive months.